News|Videos|November 27, 2023

LIGHTHOUSE Instruments Launches New Products for Robust Headspace Data Generation at the CPHI in Barcelona

LIGHTHOUSE Instruments introduces new technology for robust headspace data generation and areas of application.

At CPHI 2023, PharmTech Europe spoke with LIGHTHOUSE Instruments regarding the company's new products for robust headspace data generation. Learn more about:

  • How LIGHTHOUSE Instruments supports customers to generate science-based product and process data.
  • In which application areas laser-based headspace analysis is the preferred method over traditional methods used in the pharmaceutical industry.
  • An introduction to new headspace platforms for efficient robust data generation.

Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.